Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Experimentica is a private preclinical ophthalmology contract research organization focused on ocular drug discovery and development. The company provides in vitro, ex vivo, and in vivo ocular disease models, pharmacology and efficacy studies, PK/PD, biodistribution, early toxicology support, imaging, electrophysiology, histology, and biomolecular assays for pharmaceutical, biotech, and academic clients. Its capabilities are centered on retinal and anterior segment diseases and are supported by AAALAC-accredited facilities in Finland and Lithuania. Experimentica also emphasizes AI-driven image analysis and proprietary algorithms to generate decision-supporting data for clients advancing ophthalmic programs from discovery toward IND-enabling work. Rather than developing its own therapeutic pipeline, the company operates as a specialized scientific services partner for preclinical eye research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Experimentica.